Overview
Marion Feijge practices practicing medicine in Maastricht, Netherlands.
Their clinical expertise encompasses Albright's Hereditary Osteodystrophy, Pseudohypoparathyroidism, and Blood Clots.
They are actively involved in clinical research, co-authoring 12 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Marion H. Feijge
Is Marion H. Feijge a top-rated expert for Albright's Hereditary Osteodystrophy?
MediFind is an objective health platform that identifies experts based on real-world data. Marion H. Feijge is classified as an Experienced expert for Albright's Hereditary Osteodystrophy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Marion H. Feijge participate in research or clinical trials?
Yes. Marion H. Feijge has published 12 articles and abstracts on conditions like Albright's Hereditary Osteodystrophy. You can view a list of Marion H. Feijge's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Albright's Hereditary Osteodystrophy
- Blood ClotsFeijge isExperienced. Learn about Blood Clots.
- PseudohypoparathyroidismFeijge isExperienced. Learn about Pseudohypoparathyroidism.